This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is for the delivery of a wide range of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA) under the Medical Supply Chain division. The contract, valued at up to $18,526.83, is a firm fixed-price delivery order with no set-aside designation. It covers the supply of various medications, including branded and generic prescription drugs, over-the-counter products, biologics, and medical consumables to support the recurring medical needs of military health facilities and VA medical centers nationwide. This award is part of a larger indefinite delivery contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December 31, 2025. Through this IDC, the company provides both routine and critical pharmaceutical products to fulfill the diverse medical requirements of the Department of Defense healthcare system.
Generated 12/16/24, 2:13 PM